235 related articles for article (PubMed ID: 27881063)
1. Membrane Bioreactors for Pharmaceutical Applications: Optically Pure Enantiomers Production.
Piacentini E; Mazzei R; Giorno L
Curr Pharm Des; 2017; 23(2):250-262. PubMed ID: 27881063
[TBL] [Abstract][Full Text] [Related]
2. Homochiral drugs: a demanding tendency of the pharmaceutical industry.
Núñez MC; García-Rubiño ME; Conejo-García A; Cruz-López O; Kimatrai M; Gallo MA; Espinosa A; Campos JM
Curr Med Chem; 2009; 16(16):2064-74. PubMed ID: 19519381
[TBL] [Abstract][Full Text] [Related]
3. Chiral Recognition for Chromatography and Membrane-Based Separations: Recent Developments and Future Prospects.
Zhao Y; Zhu X; Jiang W; Liu H; Sun B
Molecules; 2021 Feb; 26(4):. PubMed ID: 33669919
[TBL] [Abstract][Full Text] [Related]
4. Stereoselectivity in drug metabolism.
Lu H
Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):149-58. PubMed ID: 17428147
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric syntheses and transformations--tools for chirality multiplication in drug synthesis.
Gawroński J
Acta Pol Pharm; 2006; 63(5):333-51. PubMed ID: 17357583
[TBL] [Abstract][Full Text] [Related]
6. Biocatalysis: synthesis of chiral intermediates for drugs.
Patel RN
Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
[TBL] [Abstract][Full Text] [Related]
7. Enantiomeric fraction determination of 2-arylpropionic acids in a package plant membrane bioreactor.
Hashim NH; Stuetz RM; Khan SJ
Chirality; 2013 May; 25(5):301-7. PubMed ID: 23620266
[TBL] [Abstract][Full Text] [Related]
8. Scalable enantioselective processes for chiral pharmaceutical intermediates.
Iida T; Mase T
Curr Opin Drug Discov Devel; 2002 Nov; 5(6):834-51. PubMed ID: 12478715
[TBL] [Abstract][Full Text] [Related]
9. Microbial/enzymatic synthesis of chiral pharmaceutical intermediates.
Patel RN
Curr Opin Drug Discov Devel; 2003 Nov; 6(6):902-20. PubMed ID: 14758760
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and separation of optically active compounds. Part I.
Gao Y; Boschetti E; Guerrier L
Ann Pharm Fr; 1994; 52(4):184-203. PubMed ID: 7857027
[TBL] [Abstract][Full Text] [Related]
11. Application of thin-layer chromatography in enantiomeric chiral analysis-an overview.
Aboul-Enein HY; El-Awady MI; Heard CM; Nicholls PJ
Biomed Chromatogr; 1999 Dec; 13(8):531-7. PubMed ID: 10611607
[TBL] [Abstract][Full Text] [Related]
12. [Separation of chiral pharmaceutical drugs by chromatographic and electrophoretic techniques].
Morin P
Ann Pharm Fr; 2009 Jul; 67(4):241-50. PubMed ID: 19596097
[TBL] [Abstract][Full Text] [Related]
13. Review: Recent application of chiral liquid chromatography-tandem mass spectrometric methods for enantiomeric pharmaceutical and biomedical determinations.
Nie Y; Liu X; Yang X; Zhao Z
J Chromatogr Sci; 2013 Sep; 51(8):753-63. PubMed ID: 23315149
[TBL] [Abstract][Full Text] [Related]
14. Treatment of a landfill leachate containing compounds of pharmaceutical origin.
Matosić M; Terzić S; Korajlija Jakopović H; Mijatović I; Ahel M
Water Sci Technol; 2008; 58(3):597-602. PubMed ID: 18725727
[TBL] [Abstract][Full Text] [Related]
15. Enantioselective strong cation-exchange molecular recognition materials: design of novel chiral stationary phases and their application for enantioseparation of chiral bases by nonaqueous capillary electrochromatography.
Constantin S; Bicker W; Zarbl E; Lämmerhofer M; Lindner W
Electrophoresis; 2003 May; 24(10):1668-79. PubMed ID: 12761798
[TBL] [Abstract][Full Text] [Related]
16. [Preparations and biological properties of chiral compounds].
Sinko G
Arh Hig Rada Toksikol; 2005 Dec; 56(4):351-61. PubMed ID: 16370519
[TBL] [Abstract][Full Text] [Related]
17. Strategy for large-scale isolation of enantiomers in drug discovery.
Leek H; Thunberg L; Jonson AC; Öhlén K; Klarqvist M
Drug Discov Today; 2017 Jan; 22(1):133-139. PubMed ID: 27693710
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of Chirally Pure Enantiomers by Lipase.
Bhardwaj KK; Gupta R
J Oleo Sci; 2017 Oct; 66(10):1073-1084. PubMed ID: 28924089
[TBL] [Abstract][Full Text] [Related]
19. Stereochemical aspects of pharmacotherapy.
Brocks DR; Jamali F
Pharmacotherapy; 1995; 15(5):551-64. PubMed ID: 8570426
[TBL] [Abstract][Full Text] [Related]
20. The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds.
Calcaterra A; D'Acquarica I
J Pharm Biomed Anal; 2018 Jan; 147():323-340. PubMed ID: 28942107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
